These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6658906)

  • 1. Oxypurines in cerebrospinal fluid as indices of disturbed brain metabolism. A clinical study of ischemic brain diseases.
    Hällgren R; Niklasson F; Terent A; Akerblom A; Widerlöv E
    Stroke; 1983; 14(3):382-8. PubMed ID: 6658906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid ferritin in patients with cerebral infarction or bleeding.
    Hällgren R; Terent A; Wide L; Bergström K; Birgegård G
    Acta Neurol Scand; 1980 Jun; 61(6):384-92. PubMed ID: 7415809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased monoamine metabolite concentrations and cholinesterase activities in cerebrospinal fluid of patients with acute stroke.
    Wester P; Puu G; Reiz S; Winblad B; Wester PO
    Acta Neurol Scand; 1987 Dec; 76(6):473-9. PubMed ID: 3434205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentrations of nucleotides, nucleosides, purine bases, oxypurines, uric acid, and neuron-specific enolase in the cerebrospinal fluid of children with sepsis.
    Rodríguez-Núñez A; Cid E; Rodríguez-García J; Camiña F; Rodríguez-Segade S; Castro-Gago M
    J Child Neurol; 2001 Sep; 16(9):704-6. PubMed ID: 11575617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain and plasma proteins in spinal fluid as markers for brain damage and severity of stroke.
    Strand T; Alling C; Karlsson B; Karlsson I; Winblad B
    Stroke; 1984; 15(1):138-44. PubMed ID: 6198785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid ferritin in patients with meningitis and cerebral infarction or bleeding.
    Milman N; Graudal NA; Olsen TS; Wandall JH; Pedersen NS
    Dan Med Bull; 1993 Sep; 40(4):490-2. PubMed ID: 8222769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Early changes of oxypurines in rat brain following focal cerebral ischemia].
    Nihei H
    No To Shinkei; 1988 Aug; 40(8):713-9. PubMed ID: 3179084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain energy metabolism and blood-brain barrier permeability in depressive patients: analyses of creatine, creatinine, urate, and albumin in CSF and blood.
    Niklasson F; Agren H
    Biol Psychiatry; 1984 Aug; 19(8):1183-206. PubMed ID: 6498242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient neurological symptoms associated with mononuclear pleocytosis of the cerebrospinal fluid.
    Brattström L; Hindfelt B; Nilsson O
    Acta Neurol Scand; 1984 Aug; 70(2):104-10. PubMed ID: 6485744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ischemic edema in stroke. A parallel study with computed tomography and cerebrospinal fluid markers of disturbed brain cell metabolism.
    Terent A; Ronquist G; Bergström K; Hällgren R; Aberg H
    Stroke; 1981; 12(1):33-40. PubMed ID: 7222157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin in cerebrospinal fluid and plasma of patients in the early stage of ischemic stroke.
    Lampl Y; Fleminger G; Gilad R; Galron R; Sarova-Pinhas I; Sokolovsky M
    Stroke; 1997 Oct; 28(10):1951-5. PubMed ID: 9341702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxanthine, xanthine, and urate in synovial fluid from patients with inflammatory arthritides.
    Gudbjörnsson B; Zak A; Niklasson F; Hällgren R
    Ann Rheum Dis; 1991 Oct; 50(10):669-72. PubMed ID: 1958086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-activating factor (PAF) concentration and PAF acetylhydrolase activity in cerebrospinal fluid of patients with subarachnoid hemorrhage.
    Hirashima Y; Endo S; Ohmori T; Kato R; Takaku A
    J Neurosurg; 1994 Jan; 80(1):31-6. PubMed ID: 8271019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in CSF blood-brain barrier parameters in ischaemic cerebral infarction.
    Hornig CR; Busse O; Dorndorf W; Kaps M
    J Neurol; 1983; 229(1):11-6. PubMed ID: 6189973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Purine transport through the blood-brain barrier in hypoxanthine phosphoribosyltransferase deficiency].
    López Jiménez M; García Puig J; Mateos Antón F; Ramos Hernández T; Pascual Castroviejo I; Ortiz Vázquez J
    Med Clin (Barc); 1989 Feb; 92(5):167-70. PubMed ID: 2725104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cortisol in plasma and cerebrospinal fluid of patients with brain ischemia].
    Selaković V
    Med Pregl; 2004; 57(7-8):354-8. PubMed ID: 15626292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More accurate identification of reversible ischemic injury in human stroke by cerebrospinal fluid suppressed diffusion-weighted imaging.
    Bykowski JL; Latour LL; Warach S
    Stroke; 2004 May; 35(5):1100-6. PubMed ID: 15060314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in xanthine and uric acid in rat brain after middle cerebral artery occlusion].
    Kanemitsu H; Karasawa S; Nihei H; Tomukai N; Tamura A; Sano K; Iwamoto T; Yoshiura M; Iriyama K
    No To Shinkei; 1989 Feb; 41(2):157-63. PubMed ID: 2736146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood-cerebrospinal fluid barrier integrity in cerebral infarction.
    Niebrój-Dobosz I; Mariam AG; Lukasiuk M; Rafałowska J
    Neuropatol Pol; 1992; 30(1):29-33. PubMed ID: 1484607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early onset of lipid peroxidation after human traumatic brain injury: a fatal limitation for the free radical scavenger pharmacological therapy?
    Cristofori L; Tavazzi B; Gambin R; Vagnozzi R; Vivenza C; Amorini AM; Di Pierro D; Fazzina G; Lazzarino G
    J Investig Med; 2001 Sep; 49(5):450-8. PubMed ID: 11523701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.